Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesReview of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
Neuropsychiatric Disease and Treatment, 09/14/09
Ulloa CM et al. – The most common reported adverse events with levetiracetam XR were somnolence, irritability, dizziness, nausea, influenza, and nasopharyngitis. Levetiracetam XR provides an efficacious and well–tolerated treatment option for adjunctive therapy in the treatment of partial–onset seizures.
Related Articles
Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials
Epilepsia, 10/29/09
Relevance Score: 65%
Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures
Cochrane Reviews, 10/09/09
Relevance Score: 64%
Lacosamide: An Adjunctive Agent for Partial-Onset Seizures and Potential Therapy for Neuropathic Pain
Annals of Pharmacotherapy, 10/22/09
Relevance Score: 63%
Not All First Seizures Are Created Equally
Epilepsy Currents, 11/02/09
Relevance Score: 47%
Seizure Relapse and Development of Drug Resistance Following Long-term Seizure Remission
Archives of Neurology, 10/14/09
Relevance Score: 46%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies
Journal of Clinical Oncology, 12/04/09
Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES)
International Journal of Andrology, 12/04/09
Atazanavir-Associated Choledocholithiasis Leading to Acute Hepatitis in an HIV-Infected Adult
Annals of Pharmacotherapy, 12/03/09
Sponsor
Article Search
Sponsor